Oakmark
Oakmark Equity and Income Fund
Large-cap Income
Mar 2025 → Sep 2026
Our archive holds 6 letters from this strategy, behind 10 investment theses and positions in 21 companies. Every quote below is copied verbatim from the letter it came from.
6 letters in 2 years · follow all of Oakmark for every strategy.
Performance
as of Sep 30, 2026 · net of fees · USD · Institutional Class
- YTD+2.8%index +6.4%
- 1Y+6.3%index +8.6%
- 3Y · /yr+11.1%index +15.2%
- 5Y · /yr+5.8%index +8.0%
- 10Y · /yr+8.4%index +9.7%
- Inception · /yr+9.5%index +8.3%
Index: 60% S&P 500 / 40% Bloomberg U.S. Aggregate Bond Index
| YTD | 1Y | 3Yper year | 5Yper year | 10Yper year | Since inceptionper year | |
|---|---|---|---|---|---|---|
| Oakmark Equity and Income Fund | +2.8% | +6.3% | +11.1% | +5.8% | +8.4% | +9.5% |
| 60% S&P 500 / 40% Bloomberg U.S. Aggregate Bond Index | +6.4% | +8.6% | +15.2% | +8.0% | +9.7% | +8.3% |
Disclaimer
These figures are copied from the manager’s latest letter, as of Sep 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.
Read full disclosures →What it bought and sold
Final stock sales • Charles River Labs • Comcast Cl A • Nike Cl B • State Street
Final stock sales • Charles River Labs • Comcast Cl A • Nike Cl B • State Street
Final stock sales • Charles River Labs • Comcast Cl A • Nike Cl B • State Street
Final stock sales • Charles River Labs • Comcast Cl A • Nike Cl B • State Street
New purchases Elevance Health is one of the nation’s largest man- aged care organizations, serving over 45 million members across employer-sponsored and individ- ual health insurance, Medicare, and Medicaid.
Final stock sales • Phillips 66
Also held
Its investment theses
- Meta PlatformsSep 2026Meta Platforms operates Family of Apps at massive scale and offers AI monetization optionality at a valuation discount to intrinsic value.
- Rocket CompaniesSep 2026Rocket Companies is a mortgage originator and servicer with scale, a low-cost model, market-share gains, and underappreciated earnings power in a recovery.
- AlphabetJun 2026Alphabet is attractive on a sum-of-the-parts basis, with AI leadership supporting growth and monetization across Search and Cloud.
- AccentureJun 2026Accenture is viewed as undervalued, with AI-related transformation projects and long-standing client relationships expected to support renewed growth.
- Elevance HealthJun 2026Elevance Health is a large managed care franchise whose depressed earnings and margins are seen as temporary, with scale and disciplined capital allocation supporting long-term value.
- Netflix, Inc.Mar 2026Netflix, Inc. is the scaled leader in streaming with a moat from content economics and an attractive valuation despite transient concerns.
- Adobe Inc.Mar 2026Adobe Inc. is a leading cloud software company with entrenched products, a sound AI strategy, and a discounted valuation.
- Centene CorporationMar 2026Centene Corporation is the leading government managed care provider with scale advantages and cyclical margin recovery potential at a discounted valuation.
- Sysco CorporationMar 2026Sysco Corporation is a scale-advantaged foodservice distributor benefiting from secular trends and a turnaround, available at an attractive valuation.
- Roper Technologies, Inc.Mar 2026Roper Technologies, Inc. is a capital-light vertical software compounder with durable moats, strong margins, and discounted valuation.